Dr. Jeff Shuren, the head of FDA’s medical device division, told a medtech audience on a podcast released this week that the agency should “re-envision” the medical device regulatory framework.
AdvaMed released a response to the Biden administration’s announcement today of its plan to expand COVID-19 testing in our nation’s K-8 schools.
WASHINGTON, D.C. – AdvaMed, the world’s largest trade organization representing medical technology companies, released the following statement from President and CEO Scott Whitaker:
iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU).
O2TODAY (“O2TODAY”), a mask company that develops, manufactures and commercializes face masks for medical and non-medical uses, and SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original…
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed)—the world’s largest trade association for medical technology and diagnostics companies in the world—released the following statement from President and CEO Scott Whitaker on…
AdvaMed unveiled a newly repurposed platform to help device manufacturers locate and partner with thousands of component part manufacturers and sellers, should they need them during the COVID pandemic.
AdvaMed President and CEO Scott Whitaker released a statement on the announcement by the European Union that COVID-19 vaccines covered by an Advanced Purchase Agreement (APA) require in many instances…
WASHINGTON, D.C. – Today AdvaMed President and CEO Scott Whitaker sent a letter to President Biden affirming the industry’s support of the administration’s national COVID-19 strategy and sharing the industry’s perspective on…
WASHINGTON, D.C. – Today AdvaMed President and CEO Scott Whitaker released the following statement about AdvaMed’s participation on the HHS Vaccine Consultation Panel.